Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Nicotine Transdermal Patch

Known as: Nicotine patch, Transdermal Patch, Nicotine, Patch, Nicotine Transdermal 
A transdermal patch containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the patch, nicotine is slowly… Expand
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

24 HR Nicotine 0.292 MG/HR Transdermal System24 HR Nicotine 0.875 MG/HR Transdermal System

Broader (2)

Nicotinenicotine replacement

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Electronic cigarettes for smoking cessation: a randomised controlled trial
BACKGROUND Electronic cigarettes (e-cigarettes) can deliver nicotine and mitigate tobacco withdrawal and are used by many smokers… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2008
Highly Cited
2008
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
Background: Varenicline, a new treatment for smoking cessation, has demonstrated significantly greater efficacy over placebo and… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Review
2004
Review
2004
Current status and future potential of transdermal drug delivery
The past twenty five years have seen an explosion in the creation and discovery of new medicinal agents. Related innovations in… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Highly Cited
2003
Highly Cited
2003
Nicotine replacement therapy in smoking cessation.
Evidence for benefit from nicotine replacement therapy in hospital patients is inconclusive, although the results of a trial… Expand
  • table 1
Highly Cited
1999
Highly Cited
1999
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
BACKGROUND AND METHODS Use of nicotine-replacement therapies and the antidepressant bupropion helps people stop smoking. We… Expand
  • figure 1
  • figure 2
  • table 3
Highly Cited
1999
Highly Cited
1999
Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease
Rationale: Acute nicotine injections have been found to improve attentional performance in patients with Alzheimer’s disease (AD… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Highly Cited
1998
Highly Cited
1998
Transdermal nicotine effects on attention
Abstract Nicotine has been shown to improve attentiveness in smokers and attenuate attentional deficits in Alzheimer’s disease… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Highly Cited
1996
Highly Cited
1996
Modulation of oxidant stress in vivo in chronic cigarette smokers.
BACKGROUND Free radical-induced oxidative damage is thought to be involved in the pathogenesis of diseases associated with… Expand
Highly Cited
1994
Highly Cited
1994
Transdermal nicotine for active ulcerative colitis.
BACKGROUND Ulcerative colitis is largely a disease of nonsmokers. Because anecdotal reports suggest that smoking and nicotine may… Expand
Highly Cited
1994
Highly Cited
1994
Predicting smoking cessation. Who will quit with and without the nicotine patch.
OBJECTIVE To identify predictors of smoking cessation success or failure with and without transdermal nicotine patch treatment… Expand
  • table 1
  • table 2
  • table 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE